GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ZimVie Inc (NAS:ZIMV) » Definitions » Beneish M-Score

ZimVie (ZimVie) Beneish M-Score : -4.21 (As of Apr. 26, 2024)


View and export this data going back to 2022. Start your Free Trial

What is ZimVie Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.21 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for ZimVie's Beneish M-Score or its related term are showing as below:

ZIMV' s Beneish M-Score Range Over the Past 10 Years
Min: -4.21   Med: -4.16   Max: -4.11
Current: -4.21

During the past 6 years, the highest Beneish M-Score of ZimVie was -4.11. The lowest was -4.21. And the median was -4.16.


ZimVie Beneish M-Score Historical Data

The historical data trend for ZimVie's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZimVie Beneish M-Score Chart

ZimVie Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - - - -4.11 -4.21

ZimVie Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.11 -2.81 -2.81 -2.83 -4.21

Competitive Comparison of ZimVie's Beneish M-Score

For the Medical Devices subindustry, ZimVie's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ZimVie's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ZimVie's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where ZimVie's Beneish M-Score falls into.



ZimVie Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of ZimVie for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0147+0.528 * 0.9995+0.404 * 0.8707+0.892 * 0.9874+0.115 * 0.9788
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.996+4.679 * -0.341039-0.327 * 1.2403
=-4.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $74.8 Mil.
Revenue was -195.762 + 202.872 + 224.896 + 225.427 = $457.4 Mil.
Gross Profit was -152.018 + 137.624 + 150.396 + 154.382 = $290.4 Mil.
Total Current Assets was $482.9 Mil.
Total Assets was $1,205.3 Mil.
Property, Plant and Equipment(Net PPE) was $54.2 Mil.
Depreciation, Depletion and Amortization(DDA) was $121.7 Mil.
Selling, General, & Admin. Expense(SGA) was $249.0 Mil.
Total Current Liabilities was $173.6 Mil.
Long-Term Debt & Capital Lease Obligation was $517.9 Mil.
Net Income was -334.852 + -5.089 + -23.373 + -29.968 = $-393.3 Mil.
Non Operating Income was 1.889 + -4.442 + -9.243 + -7.564 = $-19.4 Mil.
Cash Flow from Operations was 21.454 + 22.634 + 0.256 + -7.196 = $37.1 Mil.
Total Receivables was $74.7 Mil.
Revenue was -221.45 + 214.577 + 234.564 + 235.601 = $463.3 Mil.
Gross Profit was -164.287 + 154.947 + 153.492 + 149.794 = $293.9 Mil.
Total Current Assets was $537.9 Mil.
Total Assets was $1,642.1 Mil.
Property, Plant and Equipment(Net PPE) was $58.5 Mil.
Depreciation, Depletion and Amortization(DDA) was $122.8 Mil.
Selling, General, & Admin. Expense(SGA) was $253.2 Mil.
Total Current Liabilities was $217.3 Mil.
Long-Term Debt & Capital Lease Obligation was $542.2 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(74.809 / 457.433) / (74.668 / 463.292)
=0.163541 / 0.161168
=1.0147

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(293.946 / 463.292) / (290.384 / 457.433)
=0.634472 / 0.634812
=0.9995

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (482.877 + 54.167) / 1205.345) / (1 - (537.863 + 58.5) / 1642.056)
=0.554448 / 0.636819
=0.8707

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=457.433 / 463.292
=0.9874

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(122.789 / (122.789 + 58.5)) / (121.686 / (121.686 + 54.167))
=0.677311 / 0.691976
=0.9788

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(248.965 / 457.433) / (253.158 / 463.292)
=0.544265 / 0.546433
=0.996

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((517.877 + 173.614) / 1205.345) / ((542.193 + 217.309) / 1642.056)
=0.573687 / 0.462531
=1.2403

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-393.282 - -19.36 - 37.148) / 1205.345
=-0.341039

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

ZimVie has a M-score of -4.21 suggests that the company is unlikely to be a manipulator.


ZimVie (ZimVie) Business Description

Traded in Other Exchanges
Address
10225 Westmoor Drive, Westminster, CO, USA, 80021
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
Executives
Camber Capital Management Lp 10 percent owner 101 HUNTINGTON AVENUE, SUITE 2101, BOSTON MA 02199
Sally Crawford director C/O HOLOGIC, INC., BEDFORD MA 01730
Vafa Jamali director, officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Richard Heppenstall officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Zimmer Biomet Holdings, Inc. 10 percent owner 345 EAST MAIN STREET, WARSAW IN 46580
Richard Kuntz director MEDTRONIC, INC., 710 MEDTRONIC PWKY MS LC 310, MINNEAPOLIS MN 55432
Vinit K Asar director 10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Karen Matusinec director C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David P King director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Rebecca Ann Whitney officer: See Remarks 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David John Harmon officer: See Remarks 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Indraneel Kanaglekar officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Heather Kidwell officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Sandra Schneider officer: Chief Accounting Officer C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021